WROC&LSTROKAWSKIE CENTRUM BADA&NACUTE EIT + SPO&LSTROKKA Z OGRANICZON&AOGON ODPOWIEDZIALNO&SACUTECIĄWROCŁAWSKIE CENTRUM BADAŃ EIT + SPOŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
The subject of the present invention is the use of bacitracin for the hydrolytic degradation of RNA, occurring at guanosine residues, preferably in single-stranded RNA regions, and occurring without the involvement of transition metal ions. According to the invention, it is possible to use bacitracin according to a mechanism dependent on the degradation of undesirable RNA, different than that stipulated to-date.